The United Nations Development Programme (UNDP) has delivered 3,000 antiretroviral drugs to Fiji, aiming to address a troubling increase in HIV cases.
Last year, Fiji’s Ministry of Health and Medical Services reported 552 new HIV cases between January and June. By mid-December, 19 children under five were diagnosed, primarily due to mother-to-child transmission.
Consultant Pediatrician Dr. Priya Kaur from the Colonial War Memorial Hospital highlighted gaps in care: “We probably failed to test [the mother] or even if we tested her, something happened and she didn’t take her antiretroviral during pregnancy; and that’s how the baby got it. It’s a long journey for a child to be infected.”
Fiji’s Health Minister, Dr. Atonio Lalabalavu, said the UNDP partnership ensures consistent care while strengthening the nation’s capacity to combat the outbreak. “Testing and adherence to treatment are key to mitigating further spread,” he said.
In July 2024, UNDP and the Ministry signed a financing agreement under the Multi-country Western Pacific Programme, enabling efficient procurement and delivery of essential HIV, STI, and TB supplies.
“Access to life-saving treatment is essential for safeguarding public health,” said Munkhtuya Altangerel, UNDP’s resident representative for the Pacific.
The Fiji Medical Association has urged the government to declare an HIV outbreak.